FDA Flexibility Leads to First Approved Gene Therapy for Rare Blood & Immune System Disorder

Waskyra is the first FDA-approved gene therapy for the rare disease Wiskott-Aldrich syndrome and the first such approved product from a non-profit applicant, Fondazione Telethon. Data from Waskyra’s pivotal studies were presented this week during the annual meeting of the American Society of Hematology. The post FDA Flexibility Leads to First Approved Gene Therapy for…

Read More

Steps or Surgery: The Case for Wearables

Relentlessly, rates of chronic disease, depression, and medication use continue to rise — if there were ever a time to implement alternative preventive health tools in clinical practice, now is certainly it.  The post Steps or Surgery: The Case for Wearables appeared first on MedCity News.

Read More

KFF Tracking Poll on Health Information and Trust: Trust in the CDC and Views of Federal Childhood Vaccine Schedule Changes

Weeks after the Trump administration reduced the number of childhood vaccine recommended for routine use, public trust in the CDC is at its lowest since the COVID-19 pandemic, and less than half are confident in federal agencies’ ability to make such recommendations. Among those who have heard about the revised recommendations, more say they expect…

Read More